Genetic p53 Deficiency Partially Rescues the Adrenocortical Dysplasia Phenotype at the Expense of Increased Tumorigenesis

Cancer Cell

Volumn 15, Issue 6, 2009, Pages 465-476

  Else, Tobias ^a   Trovato, Alessia ^a   Kim, Alex C ^a   Wu, Yipin ^b   Ferguson, David O ^b   Kuick, Rork D ^b   Lucas, Peter C ^b   Hammer, Gary D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

CELLCYCLE

Indexed keywords

PROTEIN P53;

ADRENAL CORTEX INSUFFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; GENE MUTATION; GERM CELL; HYPERPIGMENTATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WEANING;

MUS;

EID: 65649133036     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.04.011     Document Type: Article

References (63)

1. Achermann J.C., Gu W.X., Kotlar T.J., Meeks J.J., Sabacan L.P., Seminara S.B., Habiby R.L., Hindmarsh P.C., Bick D.P., Sherins R.J., et al. Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. J. Clin. Endocrinol. Metab. 84 (1999) 4497-4500
2. Artandi S.E. Telomere shortening and cell fates in mouse models of neoplasia. Trends Mol. Med. 8 (2002) 44-47
3. Artandi S.E., and DePinho R.A. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10 (2000) 39-46
4. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., and DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406 (2000) 641-645
5. Atoyan R.Y., Sharov A.A., Eller M.S., Sargsyan A., Botchkarev V.A., and Gilchrest B.A. Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicle. Exp. Dermatol. 16 (2007) 671-677
6. Beamer W.G., Sweet H.O., Bronson R.T., Shire J.G., Orth D.N., and Davisson M.T. Adrenocortical dysplasia: a mouse model system for adrenocortical insufficiency. J. Endocrinol. 141 (1994) 33-43
7. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 6 (2005) 611-622
8. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., and Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91 (1997) 25-34
9. Celli G.B., and de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 7 (2005) 712-718
10. Chiang Y.J., Kim S.H., Tessarollo L., Campisi J., and Hodes R.J. Telomere-associated protein TIN2 is essential for early embryonic development through a telomerase-independent pathway. Mol. Cell. Biol. 24 (2004) 6631-6634
11. Chida D., Nakagawa S., Nagai S., Sagara H., Katsumata H., Imaki T., Suzuki H., Mitani F., Ogishima T., Shimizu C., et al. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl. Acad. Sci. USA 104 (2007) 18205-18210
12. Chin K., de Solorzano C.O., Knowles D., Jones A., Chou W., Rodriguez E.G., Kuo W.L., Ljung B.M., Chew K., Myambo K., et al. In situ analyses of genome instability in breast cancer. Nat. Genet. 36 (2004) 984-988
13. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., and DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97 (1999) 527-538
14. Choi J., Southworth L.K., Sarin K.Y., Venteicher A.S., Ma W., Chang W., Cheung P., Jun S., Artandi M.K., Shah N., et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 4 (2008) e10
15. Cosme-Blanco W., Shen M.F., Lazar A.J., Pathak S., Lozano G., Multani A.S., and Chang S. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep. 8 (2007) 497-503
16. Cui R., Widlund H.R., Feige E., Lin J.Y., Wilensky D.L., Igras V.E., D'Orazio J., Fung C.Y., Schanbacher C.F., Granter S.R., and Fisher D.E. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128 (2007) 853-864
17. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19 (2005) 2100-2110
18. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery Jr. C.A., Butel J.S., and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 (1992) 215-221
19. Else T., and Hammer G.D. Genetic analysis of adrenal absence: agenesis and aplasia. Trends Endocrinol. Metab. 16 (2005) 458-468
20. Else T., Theisen B.K., Wu Y., Hutz J.E., Keegan C.E., Hammer G.D., and Ferguson D.O. Tpp1/Acd maintains genomic stability through a complex role in telomere protection. Chromosome Res. 15 (2007) 1001-1013
21. Else T., Giordano T.J., and Hammer G.D. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 93 (2008) 1442-1449
22. Enders G.C., and May II J.J. Developmentally regulated expression of a mouse germ cell nuclear antigen examined from embryonic day 11 to adult in male and female mice. Dev. Biol. 163 (1994) 331-340
23. Farazi P.A., Glickman J., Jiang S., Yu A., Rudolph K.L., and DePinho R.A. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res. 63 (2003) 5021-5027
24. Feig C., Kirchhoff C., Ivell R., Naether O., Schulze W., and Spiess A.N. A new paradigm for profiling testicular gene expression during normal and disturbed human spermatogenesis. Mol. Hum. Reprod. 13 (2007) 33-43
25. Greider C.W. Telomere length regulation. Annu. Rev. Biochem. 65 (1996) 337-365
26. Guo X., Deng Y., Lin Y., Cosme-Blanco W., Chan S., He H., Yuan G., Brown E.J., and Chang S. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J. 26 (2007) 4709-4719
27. Hadshiew I., Barre K., Bodo E., Funk W., and Paus R. T-oligos as differential modulators of human scalp hair growth and pigmentation: a new "time lapse system" for studying human skin and hair follicle biology in vitro?. Arch. Dermatol. Res. 300 (2008) 155-159
28. Hande M.P., Samper E., Lansdorp P., and Blasco M.A. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144 (1999) 589-601
29. Hemann M.T., and Greider C.W. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res. 28 (2000) 4474-4478
30. Hemann M.T., Rudolph K.L., Strong M.A., DePinho R.A., Chin L., and Greider C.W. Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol. Biol. Cell 12 (2001) 2023-2030
31. Hockemeyer D., Daniels J.P., Takai H., and de Lange T. Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell 126 (2006) 63-77
32. Hockemeyer D., Palm W., Else T., Daniels J.P., Takai K.K., Ye J.Z., Keegan C.E., de Lange T., and Hammer G.D. Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat. Struct. Mol. Biol. 14 (2007) 754-761
33. Houghtaling B.R., Cuttonaro L., Chang W., and Smith S. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr. Biol. 14 (2004) 1621-1631
34. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., and Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4 (1994) 1-7
35. Jacobs J.J., and de Lange T. Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr. Biol. 14 (2004) 2302-2308
36. Ju Z., and Rudolph K.L. Telomeres and telomerase in cancer stem cells. Eur. J. Cancer 42 (2006) 1197-1203
37. Karlseder J., Kachatrian L., Takai H., Mercer K., Hingorani S., Jacks T., and de Lange T. Targeted deletion reveals an essential function for the telomere length regulator Trf1. Mol. Cell. Biol. 23 (2003) 6533-6541
38. Keegan C.E., Hutz J.E., Else T., Adamska M., Shah S.P., Kent A.E., Howes J.M., Beamer W.G., and Hammer G.D. Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator. Hum. Mol. Genet. 14 (2005) 113-123
39. Khlgatian M.K., Hadshiew I.M., Asawanonda P., Yaar M., Eller M.S., Fujita M., Norris D.A., and Gilchrest B.A. Tyrosinase gene expression is regulated by p53. J. Invest. Dermatol. 118 (2002) 126-132
40. Kim J., Chu J., Shen X., Wang J., and Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132 (2008) 1049-1061
41. Lee H.W., Blasco M.A., Gottlieb G.J., Horner II J.W., Greider C.W., and DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature 392 (1998) 569-574
42. Liu D., Safari A., O'Connor M.S., Chan D.W., Laegeler A., Qin J., and Songyang Z. PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol. 6 (2004) 673-680
43. Liu Y., Snow B.E., Hande M.P., Yeung D., Erdmann N.J., Wakeham A., Itie A., Siderovski D.P., Lansdorp P.M., Robinson M.O., and Harrington L. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr. Biol. 10 (2000) 1459-1462
44. Luo X., Ikeda Y., Lala D.S., Baity L.A., Meade J.C., and Parker K.L. A cell-specific nuclear receptor plays essential roles in adrenal and gonadal development. Endocr. Res. 21 (1995) 517-524
45. Maser R.S., and DePinho R.A. Connecting chromosomes, crisis, and cancer. Science 297 (2002) 565-569
46. Meeker A.K., Gage W.R., Hicks J.L., Simon I., Coffman J.R., Platz E.A., March G.E., and De Marzo A.M. Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. Am. J. Pathol. 160 (2002) 1259-1268
47. Mendiola M., Carrillo J., Garcia E., Lalli E., Hernandez T., de Alava E., Tirode F., Delattre O., Garcia-Miguel P., Lopez-Barea F., et al. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Int. J. Cancer 118 (2006) 1381-1389
48. Niakan K.K., Davis E.C., Clipsham R.C., Jiang M., Dehart D.B., Sulik K.K., and McCabe E.R. Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. Mol. Genet. Metab. 88 (2006) 261-271
49. O'Connor M.S., Safari A., Xin H., Liu D., and Songyang Z. A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc. Natl. Acad. Sci. USA 103 (2006) 11874-11879
50. O'Hagan R.C., Chang S., Maser R.S., Mohan R., Artandi S.E., Chin L., and DePinho R.A. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2 (2002) 149-155
51. Poncet D., Belleville A., de Roodenbeke C.T., de Climens A.R., Simon E.B., Merle-Beral H., Callet-Bauchu E., Salles G., Sabatier L., Delic J., and Gilson E. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood 111 (2008) 2388-2391
52. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., and DePinho R.A. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96 (1999) 701-712
53. Rudolph K.L., Millard M., Bosenberg M.W., and DePinho R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28 (2001) 155-159
54. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., Artandi M.K., Oro A.E., and Artandi S.E. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436 (2005) 1048-1052
55. Schrader M., Muller M., Schulze W., Heicappell R., Krause H., Straub B., and Miller K. Quantification of telomerase activity, porphobilinogen deaminase and human telomerase reverse transcriptase mRNA in testicular tissue-new parameters for a molecular diagnostic classification of spermatogenesis disorders. Int. J. Androl. 25 (2002) 34-44
56. Smogorzewska A., and de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21 (2002) 4338-4348
57. Tabori U., Nanda S., Druker H., Lees J., and Malkin D. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res. 67 (2007) 1415-1418
58. van Steensel B., Smogorzewska A., and de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 92 (1998) 401-413
59. Vega F., Cho-Vega J.H., Lennon P.A., Luthra M.G., Bailey J., Breeden M., Jones D., Medeiros L.J., and Luthra R. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes. Br. J. Haematol. 142 (2008) 216-226
60. Wu L., Multani A.S., He H., Cosme-Blanco W., Deng Y., Deng J.M., Bachilo O., Pathak S., Tahara H., Bailey S.M., et al. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126 (2006) 49-62
61. Xin H., Liu D., Wan M., Safari A., Kim H., Sun W., O'Connor M.S., and Songyang Z. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 445 (2007) 559-562
62. Ye J.Z., Hockemeyer D., Krutchinsky A.N., Loayza D., Hooper S.M., Chait B.T., and de Lange T. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 18 (2004) 1649-1654
63. Zanaria E., Muscatelli F., Bardoni B., Strom T.M., Guioli S., Guo W., Lalli E., Moser C., Walker A.P., McCabe E.R., et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372 (1994) 635-641